Target intelligence / Profile preview

Gut microbiota-host innate immune system axis

Molecular classification
Other
01

Overview

The gut microbiota and host innate immune system constitute a complex, bidirectional communication axis essential for maintaining physiological homeostasis and immune tolerance (Belkaid & Hand, 2014, Science). The innate immune system utilizes pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), to sense microbe-associated molecular patterns (MAMPs) and metabolites like short-chain fatty acids (SCFAs) produced by commensal bacteria (Hooper et al., 2012, Science). This interaction is critical for the maturation of immune cells, the maintenance of the intestinal epithelial barrier, and the prevention of pathogen colonization (Thaiss et al., 2016, Nature). Dysregulation of this axis, often termed dysbiosis, is linked to a wide range of pathologies, including inflammatory bowel disease (IBD), obesity, and autoimmune disorders (Zheng et al., 2020, Cell Research). Therapeutic strategies targeting this system include the use of probiotics, prebiotics, and fecal microbiota transplants to restore a healthy microbial balance and modulate host immune signaling (Cani, 2018, Gut). Because this entry describes a broad physiological interaction involving numerous distinct proteins and organisms rather than a single molecular entity, it is classified as a biological system or axis.

Other names
Gut-immune axisMicrobiome-innate immunity crosstalkCommensal-host immune interactionGut microbiota-host immune system interface
02

Mechanism of action

Modulation of the intestinal microbial ecosystem and its metabolic byproducts to regulate host innate immune signaling via pattern recognition receptors (PRRs) and maintain epithelial barrier integrity (Belkaid & Hand, 2014, Science; Cani, 2018, Gut).

03

Biological functions

Immune responseMetabolismSignal transductionHomeostasisCellular defense
04

Disease associations

InflammationInfectionAutoimmune diseaseMetabolic syndromeInflammatory bowel diseaseCancer
05

Safety considerations

Risk of systemic infection or sepsis in immunocompromised individualsPotential for inducing or exacerbating dysbiosisHigh variability in individual response to microbial modulationRisk of transferring pathogens during fecal microbiota transplant
06

Interacting drugs

Rifaximin

5 more in the full profile.

07

Biomarkers

Microbial alpha diversity indexFecal calprotectinShort-chain fatty acid (SCFA) levelsSecretory IgAC-reactive protein (CRP)

Beyond the preview

Go deeper on Gut microbiota-host innate immune system axis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota-host innate immune system axis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call